<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02500056</url>
  </required_header>
  <id_info>
    <org_study_id>10100</org_study_id>
    <nct_id>NCT02500056</nct_id>
  </id_info>
  <brief_title>Study Evaluating the Impact of Mesh Pore Size on Chronic Pain After Lichtenstein Hernioplasty</brief_title>
  <official_title>Single-centre Single-blinded Randomised Study Evaluating the Impact of Mesh Pore Size on Chronic Pain After Lichtenstein Hernioplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tartu University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tartu University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study is to determine whether usage of mesh with larger pores,
      compared with mesh with smaller pores, would result in decreased rate of chronic pain after
      open inguinal hernia repair.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the present study is to determine whether usage of mesh with larger pores,
      compared with mesh with smaller pores, would result in decreased rate of chronic pain after
      open inguinal hernia repair. The patients are randomized into two study gropus receiving mesh
      with different pore size. Clinical follow-up examination will be performed 1 week, 1 month, 6
      months and 3 years after the operation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Chronic Pain</measure>
    <time_frame>6-month follow-up</time_frame>
    <description>On visual analogue scale pain measurement at rest, on coughing, when rising from lying to sitting and during physical effort and exercise</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Chronic Pain</measure>
    <time_frame>3-year follow-up</time_frame>
    <description>On visual analogue scale pain measurement at rest, on coughing, when rising from lying to sitting and during physical effort and exercise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Foreign Body Feeling</measure>
    <time_frame>6-month follow-up</time_frame>
    <description>The question about foreign body feeling was a yes-or-no question</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">143</enrollment>
  <condition>Inguinal Hernia</condition>
  <arm_group>
    <arm_group_label>OM group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Optilene LP mesh</description>
  </arm_group>
  <arm_group>
    <arm_group_label>UM group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrapro mesh</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optilene LP mesh</intervention_name>
    <description>Lichtenstein hernioplasty</description>
    <arm_group_label>OM group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrapro mesh</intervention_name>
    <description>Lichtenstein hernioplasty</description>
    <arm_group_label>UM group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age â‰¥18 years

          -  unilateral primary reducible inguinal hernia

          -  elective operation

          -  consent to participate in the study.

        Exclusion Criteria:

          -  age &lt;18 years

          -  irreducible

          -  strangulated

          -  recurrent hernia

          -  inability to understand the questionnaire

          -  unwillingness to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 10, 2015</study_first_submitted>
  <study_first_submitted_qc>July 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 16, 2015</study_first_posted>
  <results_first_submitted>April 20, 2016</results_first_submitted>
  <results_first_submitted_qc>April 25, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">June 6, 2017</results_first_posted>
  <last_update_submitted>June 8, 2017</last_update_submitted>
  <last_update_submitted_qc>June 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tartu University Hospital</investigator_affiliation>
    <investigator_full_name>Ceith Nikkolo</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Inguinal hernia</keyword>
  <keyword>Chronic pain</keyword>
  <keyword>Mesh</keyword>
  <keyword>Lichtenstein hernioplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>OM Group</title>
          <description>Optilene LP mesh
Optilene LP mesh: Lichtenstein hernioplasty</description>
        </group>
        <group group_id="P2">
          <title>UM Group</title>
          <description>Ultrapro mesh
Ultrapro mesh: Lichtenstein hernioplasty</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="70"/>
                <participants group_id="P2" count="73"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="63"/>
                <participants group_id="P2" count="65"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Recurrence</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>OM Group</title>
          <description>Optilene LP mesh
Optilene LP mesh: Lichtenstein hernioplasty</description>
        </group>
        <group group_id="B2">
          <title>UM Group</title>
          <description>Ultrapro mesh
Ultrapro mesh: Lichtenstein hernioplasty</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="63"/>
            <count group_id="B2" value="65"/>
            <count group_id="B3" value="128"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <description>&gt;=18 years</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&gt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="65"/>
                    <measurement group_id="B3" value="128"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <description>Gender (male + female)</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Unilateral inguinal hernia</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="65"/>
                    <measurement group_id="B3" value="128"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Primary inguinal hernia</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="65"/>
                    <measurement group_id="B3" value="128"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Reducible inguinal hernia</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="65"/>
                    <measurement group_id="B3" value="128"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Elective operation</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="65"/>
                    <measurement group_id="B3" value="128"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Chronic Pain</title>
        <description>On visual analogue scale pain measurement at rest, on coughing, when rising from lying to sitting and during physical effort and exercise</description>
        <time_frame>6-month follow-up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>OM Group</title>
            <description>Optilene LP mesh
Optilene LP mesh: Lichtenstein hernioplasty</description>
          </group>
          <group group_id="O2">
            <title>UM Group</title>
            <description>Ultrapro mesh
Ultrapro mesh: Lichtenstein hernioplasty</description>
          </group>
        </group_list>
        <measure>
          <title>Chronic Pain</title>
          <description>On visual analogue scale pain measurement at rest, on coughing, when rising from lying to sitting and during physical effort and exercise</description>
          <units>percentage of patients with pain</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="67"/>
                <count group_id="O2" value="67"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.3"/>
                    <measurement group_id="O2" value="46.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Chronic Pain</title>
        <description>On visual analogue scale pain measurement at rest, on coughing, when rising from lying to sitting and during physical effort and exercise</description>
        <time_frame>3-year follow-up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>OM Group</title>
            <description>Optilene LP mesh
Optilene LP mesh: Lichtenstein hernioplasty</description>
          </group>
          <group group_id="O2">
            <title>UM Group</title>
            <description>Ultrapro mesh
Ultrapro mesh: Lichtenstein hernioplasty</description>
          </group>
        </group_list>
        <measure>
          <title>Chronic Pain</title>
          <description>On visual analogue scale pain measurement at rest, on coughing, when rising from lying to sitting and during physical effort and exercise</description>
          <units>percentage of patients with pain</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="65"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.9"/>
                    <measurement group_id="O2" value="33.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Foreign Body Feeling</title>
        <description>The question about foreign body feeling was a yes-or-no question</description>
        <time_frame>6-month follow-up</time_frame>
        <population>Drop-outs at 6-month follow-up (3+6) not included</population>
        <group_list>
          <group group_id="O1">
            <title>OM Group</title>
            <description>Optilene LP mesh
Optilene LP mesh: Lichtenstein hernioplasty</description>
          </group>
          <group group_id="O2">
            <title>UM Group</title>
            <description>Ultrapro mesh
Ultrapro mesh: Lichtenstein hernioplasty</description>
          </group>
        </group_list>
        <measure>
          <title>Foreign Body Feeling</title>
          <description>The question about foreign body feeling was a yes-or-no question</description>
          <population>Drop-outs at 6-month follow-up (3+6) not included</population>
          <units>percentage of patients with foreign body</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="67"/>
                <count group_id="O2" value="67"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.3"/>
                    <measurement group_id="O2" value="47.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3-year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>OM Group</title>
          <description>Optilene LP mesh
Optilene LP mesh: Lichtenstein hernioplasty</description>
        </group>
        <group group_id="E2">
          <title>UM Group</title>
          <description>Ultrapro mesh
Ultrapro mesh: Lichtenstein hernioplasty</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="65"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="65"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="65"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Seroma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="63"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="65"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="63"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="65"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ceith Nikkolo</name_or_title>
      <organization>Tartu University Hospital</organization>
      <phone>+37253319082</phone>
      <email>ceith.nikkolo@kliinikum.ee</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

